Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: the Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges

Archive ouverte

Meda, Nicolas | Rollins, Nigel | Luchters, Stanley | Reyners, Marcel | Nduati, Ruth | Newell, Marie-Louise | Fao, Paulin | Ky-Zerbo, Odette | Gouem, Clarisse | Mcfetridge, Lynne | Naidu, Kevi | Irungu, Eunice | Kose, Judith | Mepham, Stephen | de Vincenzi, Isabelle | Somda, Paulin | Hien, Hervé | Elysée Ouedraogo, Patrice | Kania, Dramane | Sanou, Armande | Ayassou Kossiwavi, Ida | Sanogo, Bintou | Ouedraogo, Moussa | Siribie, Issa | Katingima, Christine | Mwaura, Mary | Ouattara, Gina | Bland, Ruth, M. | Taylor, Allan | Flowers, Nicole | Thigpen, Michael | Fowler, Mary, Glenn | Jamieson, Denise | Read, Jennifer S. | Valéa, Diane | Mandaliya, Kishor | Wambua, Sammy | Njagi, Ephantus | Viljoen, Johannes | van de Perre, Philippe | Becquart, Pierre | Foulongne, Vincent | Segondy, Michel | Ouedraogo, Sayouba | Somé, Roseline | Thiongo, Mary | Mwaura, Peter | Rouet, François | Gaillard, Philippe | Bork, Kirsten, A | Cames, Cecile | Cournil, Amandine | Farley, Tim | Habib, Ndema | Landoulsi, Sihem | Bazin, Brigitte | Rekacewicz, Claire | Claeys, Patricia | Temmerman, Marleen

Edité par CCSD ; Elsevier -

International audience. To evaluate strategies to reduce HIV-1 transmission through breastfeeding, a multicentre study including a nested randomized controlled trial was implemented in five research sites in West, East and South Africa (The Kesho Bora Study). The aim was to optimize the use of antiretroviral (ARV) drugs during pregnancy, delivery and breastfeeding to prevent mother-to-child transmission of HIV-1 (PMTCT) and to preserve the health of the HIV-1-infected mother. The study included long-term ARV treatment for women with advanced disease, and short-course ARV prophylaxis stopped at delivery for women with early disease. Women with intermediate disease participated in a randomized controlled trial to compare safety and efficacy of triple-ARV prophylaxis prolonged during breastfeeding with short-course ARV prophylaxis stopped at delivery. Between January 2005 and August 2008 a total of 1140 women were enrolled. This paper describes the study design, interventions and protocol amendments introduced to adapt to evolving scientific knowledge, international guidelines and availability of ARV treatment. The paper highlights the successes and challenges during the conduct of the trial. The Kesho Bora Study included one of the few randomized controlled trials to assess safety and efficacy of ARV prophylaxis continued during breastfeeding and the only randomized trial to assess maternal prophylaxis started during pregnancy. The findings have been important for informing international and national guidelines on MTCT prevention in developing countries where, due to poverty, lack of reliable and affordable supply of replacement feed and stigma associated with HIV/AIDS, HIV-infected women have little or no option other than to breastfeed their infants. (ISRCTN71468401).

Consulter en ligne

Suggestions

Du même auteur

Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial

Archive ouverte | de Vincenzi, Isabelle | CCSD

International audience. Background : Breastfeeding is essential for child health and development in low-resource settings but carries a significant risk of transmission of HIV-1, especially in late stages of materna...

Maternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: a randomized trial in three African countries

Archive ouverte | Sartorius, Benn, K.D. | CCSD

International audience. Background: Although substantiated by little evidence, concerns about zidovudine-related anaemia in pregnancy have influenced antiretroviral (ARV) regimen choice for preventing mother-to-chil...

Maternal HIV-1 Disease Progression 18–24 Months Postdelivery According to Antiretroviral Prophylaxis Regimen (Triple-Antiretroviral Prophylaxis During Pregnancy and Breastfeeding vs Zidovudine/Single-Dose Nevirapine Prophylaxis): The Kesho Bora Randomized Controlled Trial

Archive ouverte | Meda, Nicolas | CCSD

International audience. Background : Antiretroviral (ARV) prophylaxis effectively reduces mother-to-child transmission of human immunodeficiency virus type 1 (HIV). However, it is unclear whether stopping ARVs after...

Chargement des enrichissements...